Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal on Addictions

• Publication date

  2008-01-02

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/10550490701756120PMID 18214726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2007cited by this paper
• Acamprosate for Alcohol Dependence: An Update for the Clinician

  2006cited by this paper
• Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

  2006cited by this paper
• Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

  2006cited by this paper
• Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

  2006cited by this paper
• Neuroprotective and Abstinence-Promoting Effects of Acamprosate

  2005cited by this paper
• The medical complications of alcohol use: understanding mechanisms to improve management.

  2005cited by this paper
• An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence

  2004cited by this paper
• Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol.

  2004cited by this paper
• The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.

  2004cited by this paper
• Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

  2004cited by this paper
• The 12-Month Prevalence and Trends in DSM–IV Alcohol Abuse and Dependence

  2004cited by this paper
• Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

  2003cited by this paper
• Physicians' opinions about medications to treat alcoholism.

  2003cited by this paper
• The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

  2003cited by this paper
• Current pharmacotherapies of alcoholism: a U.S. perspective.

  2003cited by this paper
• Understanding US addiction physicians' low rate of naltrexone prescription.

  2003cited by this paper
• National trends in the outpatient treatment of depression.

  2002cited by this paper
• INTERNATIONAL ADDICTIONS INFOLINE

  2000cited by this paper
• Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists.

  2000cited by this paper
• Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.

  2000cited by this paper
• Regulation of NMDA receptors by ethanol.

  2000cited by this paper
• United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

  2000cited by this paper
• Screening and intervention for alcohol problems

  2000cited by this paper
• Pharmacological treatment of alcohol dependence: a review of the evidence.

  1999cited by this paper
• Drug therapy for alcohol dependence.

  1999cited by this paper
• Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care.

  1998cited by this paper
• Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients

  1997cited by this paper
• Addiction medicine.

  1997cited by this paper
• Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.

  1996cited by this paper
• Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics.

  1996cited by this paper
• The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects.

  1996cited by this paper
• Acamprosate in alcohol dependence: how does it work?

  1995cited by this paper
• Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.

  1995cited by this paper
• Acceptance of moderate drinking by alcohol treatment services in the United States.

  1994cited by this paper

• Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C).

  2024cites this paper
• Traditional treatment strategies for alcoholism and the withdrawal symptoms

  2021cites this paper
• Pharmacotherapies and personalized medicine for alcohol use disorder: a review.

  2020cites this paper
• A randomized controlled study of the effect of ifenprodil on alcohol use in patients with alcohol dependence

  2018cites this paper
• Calcium chloride mimics the effects of acamprosate on cognitive deficits in chronic alcohol-exposed mice

  2018cites this paper
• Critical Review of Alcohol, Alcoholism and the Withdrawal Symptoms. II. Treatment Strategies

  2017cites this paper
• Assessment and Treatment of Adolescent Substance Use Disorders: Alcohol Use Disorders.

  2016cites this paper
• Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity.

  2016cites this paper
• Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.

  2016cites this paper
• Assessing ethanol's actions in the suprachiasmatic circadian clock using in vivo and in vitro approaches.

  2015cites this paper
• Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.

  2015cites this paper
• Agomelatine

  2015cites this paper
• Epidemiology and Management of Alcohol Misuse Comorbid with other Disorders

  2014cites this paper
• The development of acamprosate as a treatment against alcohol relapse

  2014cites this paper
• Pharmacotherapy of alcohol use disorders: seventy-five years of progress.

  2014cites this paper
• Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism.

  2014cites this paper
• A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol

  2013cites this paper
• The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies.

  2013cites this paper
• Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

  2013cites this paper
• Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.

  2013cites this paper
• Safety and Efficacy of Acamprosate for the Treatment of Alcohol Dependence

  2013cites this paper
• Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.

  2013cites this paper
• Pharmacotherapy for alcohol dependence: status of current treatments.

  2013cites this paper
• Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.

  2012cites this paper
• Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions

  2012cites this paper
• Alcohol Craving, Glutamate and Acamprosate

  2012cites this paper
• Glutamatergic medications for the treatment of drug and behavioral addictions.

  2012cites this paper
• Current progress in pharmacologic treatment strategies for alcohol dependence

  2012cites this paper
• Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder.

  2012cites this paper
• Management of alcohol abuse.

  2012cites this paper
• Acamprosate-responsive brain sites for suppression of ethanol intake and preference.

  2011cites this paper
• Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

  2011cites this paper
• Medications for Unhealthy Alcohol Use

  2011cites this paper
• TREATMENT Why is Disulfiram Superior to Acamprosate in the Routine Clinical Setting? A Retrospective Long-Term Study in 353 Alcohol-Dependent Patients

  2010cites this paper
• TREATMENT Why is Disul fi ram Superior to Acamprosate in the Routine Clinical Setting? A Retrospective Long-Term Study in 353 Alcohol-Dependent Patients

  2010cites this paper
• Pharmacogenetics of alcohol and alcohol dependence treatment.

  2010cites this paper
• Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence.

  2010cites this paper
• Role of the Human Laboratory in the Development of Medications for Alcohol and Drug Dependence

  2010cites this paper
• Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.

  2010cites this paper
• Acamprosate Calcium as Augmentation Therapy for Anxiety Disorders

  2010cites this paper
• Effects of Nicotine and Illicit Substance Use on Alcoholism Treatment Outcomes and Acamprosate Efficacy

  2009cites this paper
• Ethanol-induced locomotor sensitization and ethanol consumption: the role of neuropeptide Y

  2009cites this paper
• Using Neuroscience to Guide the Development of New Pharmacotherapies for Alcoholism

  2009cites this paper
• Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.

  2009cites this paper
• Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence.

  2009cites this paper
• How Adaptation of the Brain to Alcohol Leads to Dependence

  2008cites this paper
• Evidence-based treatments of addiction

  2008cites this paper
• How Adaptation of the Brain to Alcohol Leads to Dependence

  2008cites this paper
• Taurine as Drug and Functional Food Component

  2008cites this paper
• Treatment of Co-Occurring Alcohol and Other Drug Use Disorders

  2008cites this paper
• Treatment Implications

  2008cites this paper
• Substance Abuse and Rehabilitation Dovepress Alcohol Use Disorder: Pathophysiology, Effects, and Pharmacologic Options for Treatment

  year unknowncites this paper